Category: COVID-19

A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus

Even taking into account people who have had COVID but didn’t know it, there’s still likely to be a group of people who have never been infected.

  In places with low vaccination rates, Covid-19 has the chance to linger, and variants develop and travel. Without global vaccine equity, this entirely predictable pattern will repeat